459 related articles for article (PubMed ID: 22706160)
1. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor.
Zhang L; Zhou F; Drabsch Y; Gao R; Snaar-Jagalska BE; Mickanin C; Huang H; Sheppard KA; Porter JA; Lu CX; ten Dijke P
Nat Cell Biol; 2012 Jun; 14(7):717-26. PubMed ID: 22706160
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin removal in the TGF-β pathway.
Aggarwal K; Massagué J
Nat Cell Biol; 2012 Jun; 14(7):656-7. PubMed ID: 22743709
[TBL] [Abstract][Full Text] [Related]
3. AKT regulation of mesothelial-to-mesenchymal transition in peritoneal dialysis is modulated by Smurf2 and deubiquitinating enzyme USP4.
Xiao L; Peng X; Liu F; Tang C; Hu C; Xu X; Wang M; Luo Y; Yang S; Song P; Xiao P; Kanwar YS; Sun L
BMC Cell Biol; 2015 Mar; 16():7. PubMed ID: 25885904
[TBL] [Abstract][Full Text] [Related]
4. Determining TGF-β Receptor Levels in the Cell Membrane.
Zhang L; Zhou F; van Dinther M; Ten Dijke P
Methods Mol Biol; 2016; 1344():35-47. PubMed ID: 26520116
[TBL] [Abstract][Full Text] [Related]
5. PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.
Liu C; Li J; Xiang X; Guo L; Tu K; Liu Q; Shah VH; Kang N
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(7):G749-59. PubMed ID: 25169976
[TBL] [Abstract][Full Text] [Related]
6. TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α.
Hamidi A; Song J; Thakur N; Itoh S; Marcusson A; Bergh A; Heldin CH; Landström M
Sci Signal; 2017 Jul; 10(486):. PubMed ID: 28676490
[TBL] [Abstract][Full Text] [Related]
7. Tollip, an intracellular trafficking protein, is a novel modulator of the transforming growth factor-β signaling pathway.
Zhu L; Wang L; Luo X; Zhang Y; Ding Q; Jiang X; Wang X; Pan Y; Chen Y
J Biol Chem; 2012 Nov; 287(47):39653-63. PubMed ID: 23027871
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-specific protease 4 promotes metastasis of hepatocellular carcinoma by increasing TGF-β signaling-induced epithelial-mesenchymal transition.
Qiu C; Liu Y; Mei Y; Zou M; Zhao Z; Ye M; Wu X
Aging (Albany NY); 2018 Oct; 10(10):2783-2799. PubMed ID: 30335615
[TBL] [Abstract][Full Text] [Related]
9. FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis.
Xie F; Jin K; Shao L; Fan Y; Tu Y; Li Y; Yang B; van Dam H; Ten Dijke P; Weng H; Dooley S; Wang S; Jia J; Jin J; Zhou F; Zhang L
Nat Commun; 2017 Apr; 8():15021. PubMed ID: 28443643
[TBL] [Abstract][Full Text] [Related]
10. TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling.
Liu C; Xu P; Lamouille S; Xu J; Derynck R
Mol Cell; 2009 Jul; 35(1):26-36. PubMed ID: 19595713
[TBL] [Abstract][Full Text] [Related]
11. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor.
Park SJ; Choi YS; Lee S; Lee YJ; Hong S; Han S; Kim BC
Cancer Lett; 2016 Oct; 381(2):314-22. PubMed ID: 27543359
[TBL] [Abstract][Full Text] [Related]
12. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma.
Eichhorn PJ; Rodón L; Gonzàlez-Juncà A; Dirac A; Gili M; Martínez-Sáez E; Aura C; Barba I; Peg V; Prat A; Cuartas I; Jimenez J; García-Dorado D; Sahuquillo J; Bernards R; Baselga J; Seoane J
Nat Med; 2012 Feb; 18(3):429-35. PubMed ID: 22344298
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitination and regulation of Smad7 in the TGF-β1/Smad signaling of aristolochic acid nephropathy.
Tian Y; Liao F; Wu G; Chang D; Yang Y; Dong X; Zhang Z; Zhang Y; Wu G
Toxicol Mech Methods; 2015; 25(8):645-52. PubMed ID: 26108275
[TBL] [Abstract][Full Text] [Related]
14. USP11 augments TGFβ signalling by deubiquitylating ALK5.
Al-Salihi MA; Herhaus L; Macartney T; Sapkota GP
Open Biol; 2012 Jun; 2(6):120063. PubMed ID: 22773947
[TBL] [Abstract][Full Text] [Related]
15. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis.
Zhang L; Zhou F; García de Vinuesa A; de Kruijf EM; Mesker WE; Hui L; Drabsch Y; Li Y; Bauer A; Rousseau A; Sheppard KA; Mickanin C; Kuppen PJ; Lu CX; Ten Dijke P
Mol Cell; 2013 Sep; 51(5):559-72. PubMed ID: 23973329
[TBL] [Abstract][Full Text] [Related]
16. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth.
Micalizzi DS; Wang CA; Farabaugh SM; Schiemann WP; Ford HL
Cancer Res; 2010 Dec; 70(24):10371-80. PubMed ID: 21056993
[TBL] [Abstract][Full Text] [Related]
17. USP4 inhibits SMAD4 monoubiquitination and promotes activin and BMP signaling.
Zhou F; Xie F; Jin K; Zhang Z; Clerici M; Gao R; van Dinther M; Sixma TK; Huang H; Zhang L; Ten Dijke P
EMBO J; 2017 Jun; 36(11):1623-1639. PubMed ID: 28468752
[TBL] [Abstract][Full Text] [Related]
18. LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.
Melisi D; Ishiyama S; Sclabas GM; Fleming JB; Xia Q; Tortora G; Abbruzzese JL; Chiao PJ
Mol Cancer Ther; 2008 Apr; 7(4):829-40. PubMed ID: 18413796
[TBL] [Abstract][Full Text] [Related]
19. PICK1 promotes caveolin-dependent degradation of TGF-β type I receptor.
Zhao B; Wang Q; Du J; Luo S; Xia J; Chen YG
Cell Res; 2012 Oct; 22(10):1467-78. PubMed ID: 22710801
[TBL] [Abstract][Full Text] [Related]
20. VprBP mitigates TGF-β and Activin signaling by promoting Smurf1-mediated type I receptor degradation.
Li Y; Cui C; Xie F; Kiełbasa S; Mei H; van Dinther M; van Dam H; Bauer A; Zhang L; Ten Dijke P
J Mol Cell Biol; 2020 Feb; 12(2):138-151. PubMed ID: 31291647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
